SeyidogluNKseliEGurbanliRAydinC
GW4869, an EV release inhibitor, was subsequently used to block EV generation to test whether EVs contribute to DR-CM-induced PTX resistance in GC cells 25
In recent years, GLP-1 drugs have been brought to market to make this management much easier for patients with diabetes
We explore new methods that enhance the protective role of mucus through physical reinforcement, pathogen neutralization, muco-trapping and rehydration, as well as strategies that overcome the mucus barrier to improve drug delivery, including physical modulation, mucoadhesive design, muco-penetrating design, mucolytics and active targeting
A 50% increase in weight loss compared to semaglutide (22.5% vs 14.9%) seems too large to explain as mere enhancement
British Journal of Sports Medicine